Healthcare's Next Competitive Advantage Is Not Faster AI. It Is Governed AI.

Across the technology industry, a new argument is gaining ground. Speed is no longer the hardest part. AI has made it increasingly inexpensive to build software, automate work, and introduce new services. The harder challenge is governing what these systems do once they enter the real world. Governance, the argument runs, is the new fast.

In healthcare, that argument is not new. It is overdue.

Across industries, AI errors can carry serious consequences. But healthcare introduces a particularly direct human dimension. An error can influence a clinical decision, medication information, discharge instructions, or whether a patient successfully connects with care. The consequences are carried by people who may already be vulnerable, and they are not always easily reversed. Healthcare cannot simply adopt the technology industry's habit of moving first and answering questions later. It has to earn the right to move.

This is why I believe the defining question of healthcare's AI era is not how quickly a system can be deployed. It is how well it is governed.

Governance is often misunderstood as paperwork, compliance, or another committee slowing innovation down. That is not what I mean. Governance means that before an AI system enters a patient care workflow, someone with a name and a title has established what it is permitted to do, what information it can use, and where its authority ends. Its responses must be grounded in approved knowledge and appropriate information sources, not simply in what a model finds plausible. Its actions must be documented and auditable. There must be a clearly defined point at which a human takes over. And when something goes wrong, accountability must rest with people and institutions, never with the software itself.

But governance cannot end at deployment. Systems must be monitored, evaluated, and corrected as models, information, and clinical workflows change. Accuracy alone is not enough. Reliability, safety, fairness, privacy, and performance in the environment where a system is actually used matter just as much.

This direction is already reflected in the work of US institutions. The Office of the National Coordinator for Health Information Technology, through its HTI 1 Final Rule, established transparency requirements for predictive algorithms in certified health IT, addressing characteristics such as fairness, appropriateness, validity, effectiveness, and safety. The FDA's August 2025 guidance on predetermined change control plans for AI enabled medical device software also recognizes the importance of planned modifications, testing, and continued assurance of safety and effectiveness. Meanwhile, the National Institute of Standards and Technology's AI Risk Management Framework places governance at the center of a broader process of identifying, measuring, and managing AI risks.

These developments point to an important shift. Governance is moving beyond a general statement of responsible technology use and becoming an operational expectation.

None of this is anti innovation. It is the opposite. It is what makes innovation sustainable.

In my earlier writing, I argued that healthcare's next competitive advantage is access. I described the Trusted Intelligent Access Layer as an approach to connecting patients with care through intelligent communication, approved knowledge, integrated workflows, defined governance, and meaningful human oversight.

The idea is straightforward. Access is not simply making it easier to schedule an appointment or introducing an AI powered receptionist. It is ensuring that patients can reach the right care, receive reliable information, and be directed to a qualified human when their needs exceed the system's authority. Access that patients cannot trust is not meaningful access. It is another door they will eventually stop walking through.

The same principle applies to clinical and operational AI across healthcare.

Consider two organizations introducing AI into patient communication. One deploys quickly, but has inconsistent answers, unclear escalation procedures, and limited documentation. The other establishes approved information sources, clear operating boundaries, human escalation, and continuous performance monitoring. The second organization may take longer to prepare, but it is better positioned to expand the system across departments and services with confidence.

That is where governance becomes a competitive advantage. An ungoverned system may be easy to launch, but every incident, unanswered question, or loss of trust can make further adoption harder. A governed system is easier to evaluate, improve, and responsibly extend. Over time, that discipline can make it the faster system to scale.

For healthcare leaders, this calls for a different set of questions before approving an AI deployment:

1. Who is accountable for the system?
2. What approved information can it access?
3. What decisions or actions is it permitted to perform independently?
4. When must it stop and transfer responsibility to a human?
5. How are its performance, decisions, and failures documented and reviewed?

These are not simply technology questions. They are leadership questions.

Two qualifications are important. First, governance cannot rescue a system that should never have been deployed. Not every AI application belongs in every healthcare workflow. Second, governance that exists only in a policy document governs nothing. It must operate within the workflow itself, through permissions, approved information, documented actions, human escalation, and ongoing review.

Healthcare has always depended on trust. Patients place their privacy, their fears, and often their lives in the hands of this industry. That trust is earned through responsible decisions, professional accountability, and the consistent delivery of care. Artificial intelligence does not change that responsibility. It makes it more important.

The organizations that lead healthcare's AI era will not be the ones that moved first. They will be the ones that governed well enough to keep moving.

Sources and Further Reading

1. Office of the National Coordinator for Health Information Technology. HTI 1 Final Rule: Certification Program Updates, Algorithm Transparency, and Information Sharing.
2. US Food and Drug Administration. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence Enabled Device Software Functions, August 2025.
3. National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework, AI RMF 1.0.

About the author: Khalid Sattar is President of the American Chamber of Health. He works at the intersection of healthcare innovation, artificial intelligence, and digital transformation, connecting stakeholders across the American healthcare ecosystem.

Editorial Disclosure: This is an opinion article. It presents the views of the author, who is President of the American Chamber of Health. The institutional documents cited are public regulatory and standards publications. This article makes no product endorsements. The American Chamber of Health publishes analysis and opinion to advance informed discussion across the American healthcare ecosystem.